Literature DB >> 19451063

Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.

M Maciá I Garau1, J Solé Monné, M J Cambra Serés, C Monfà Binefa, M Peraire Llopis.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate the compliance of the prescribed OTT in a normal clinical practice and to establish the incidence, duration and causes of unplanned interruptions of radiation therapy. To quantify the impact of an institutional policy to maintain the OTT counteracting some short interruptions by treating patients on Saturday morning.
MATERIAL AND METHODS: The treatment charts of all new patients treated with curative intent in a period of one year were reviewed retrospectively. All treatments started on Monday or Tuesday and split-course was not used. The difference between the actual realized and the planned OTT was calculated as a measure of compliance. Recalculations of OTT were made to quantify the impact of compensating short gaps by treating patients on Saturday. The cause of interruption was also recorded and classified.
RESULTS: The charts of 478 consecutive patients treated with curative intent were reviewed. The overall incidence of unplanned interruptions was 76.6%. Public holidays and machine maintenance caused most of interruptions, and machine breakdown caused 13%. 17.9% of the interruptions were greater than 5 days and 5.6% greater than 10 days. Only 23.4% of patients finished their radiotherapy in the planned OTT (12.6% if no compensation on Saturday). 48.9% of head and neck cancer patients finished their treatment in the planned OTT (19.5% if no compensation on Saturday). The time in excess ranged up to 44 days, and the average time in excess was 3.3 days for the entire group (4.2 days if no compensation on Saturday). For head and neck cancer patients, the time in excess was 1.9 days (3.9 days if no compensation on Saturday).
CONCLUSIONS: This study has documented that the incidence and duration of unplanned interruptions of standard treatment schedules is a major problem in normal clinical practice. Most interruptions are short and due mainly to public holidays and machine maintenance and for these reasons they can be planned. In spite of the extra costs, counteracting some short interruptions by treating patients on Saturday is a good way to maintain the OTT without loss of local control.

Entities:  

Mesh:

Year:  2009        PMID: 19451063     DOI: 10.1007/s12094-009-0358-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  60 in total

1.  Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.

Authors:  S A Roberts; J H Hendry
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-12-01       Impact factor: 7.038

2.  Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma.

Authors:  Yoichiro Hosokawa; Hiroki Shirato; Takashi Nishioka; Kazuhiko Tsuchiya; Ta-Chen Chang; Kenji Kagei; Keiichi Ohomori; Ken-ichi Obinata; Masayuki Kaneko; Kazuo Miyasaka; Motoyasu Nakamura
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-09-01       Impact factor: 7.038

3.  Loss of local control with prolongation in radiotherapy.

Authors:  J F Fowler; M J Lindstrom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

4.  The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx.

Authors:  B Maciejewski; G Preuss-Bayer; K R Trott
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-03       Impact factor: 7.038

5.  Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers.

Authors:  C Robertson; A G Robertson; J H Hendry; S A Roberts; N J Slevin; W B Duncan; R H MacDougall; G R Kerr; B O'Sullivan; T J Keane
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-15       Impact factor: 7.038

6.  Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer.

Authors:  W Duncan; R H MacDougall; G R Kerr; D Downing
Journal:  Radiother Oncol       Date:  1996-12       Impact factor: 6.280

7.  Medulloblastoma: time-dose relationship based on a 30-year review.

Authors:  J O del Charco; T W Bolek; W M McCollough; B L Maria; A Kedar; R C Braylan; J P Mickle; J M Buatti; N P Mendenhall; R B Marcus
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-08-01       Impact factor: 7.038

8.  Effect of overall treatment time on local control in radical radiotherapy for squamous cell carcinoma of esophagus.

Authors:  M Kajanti; R Kaleta; L Kankaanranta; T Muhonen; L Holsti
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-15       Impact factor: 7.038

9.  How fast is repopulation of tumor cells during the treatment gap?

Authors:  Rafal Tarnawski; Jack Fowler; Krzysztof Skladowski; Andrzej Swierniak; Rafal Suwiński; Boguslaw Maciejewski; Andrzej Wygoda
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

10.  Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx.

Authors:  J Overgaard; M Hjelm-Hansen; L V Johansen; A P Andersen
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

View more
  8 in total

1.  The "rocky treatment course": identifying a high-risk subgroup of head and neck cancer patients for supportive interventions.

Authors:  Horia Vulpe; Janet Ellis; Shao Hui Huang; Eshetu G Atenafu; Raymond W Jang; Gary Rodin; Jolie Ringash
Journal:  Support Care Cancer       Date:  2016-11-04       Impact factor: 3.603

Review 2.  Management of interruptions in radiotherapy treatments: Adaptive implementation in high workload sites.

Authors:  Gustavo Pozo; Maria Angeles Pérez-Escutia; Ana Ruíz; Alejandro Ferrando; Ana Milanés; Eduardo Cabello; Raul Díaz; Alejandro Prado; Jose Fermin Pérez-Regadera
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-26

3.  Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients.

Authors:  Radhika Sreeraman; Srinivasan Vijayakumar; Allen M Chen
Journal:  Support Care Cancer       Date:  2013-07-28       Impact factor: 3.603

4.  Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome.

Authors:  B C Ferreira; P Sá-Couto; M C Lopes; L Khouri
Journal:  Clin Transl Oncol       Date:  2015-10-12       Impact factor: 3.405

Review 5.  Squamous-cell carcinoma of the anus: progress in radiotherapy treatment.

Authors:  Rob Glynne-Jones; David Tan; Robert Hughes; Peter Hoskin
Journal:  Nat Rev Clin Oncol       Date:  2016-01-27       Impact factor: 66.675

6.  Selective use of postoperative neck radiotherapy in oral cavity and oropharynx cancer: a prospective clinical study.

Authors:  Miguel Martínez Carrillo; Isabel Tovar Martín; Ildefonso Martínez Lara; José Mariano Ruiz de Almodóvar Rivera; Rosario Del Moral Ávila
Journal:  Radiat Oncol       Date:  2013-04-28       Impact factor: 3.481

7.  Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal.

Authors:  Meritxell Arenas; Sebastià Sabater; Marina Gascón; Ivan Henríquez; M José Bueno; Àngels Rius; Àngels Rovirosa; David Gómez; Anna Lafuerza; Albert Biete; Jordi Colomer
Journal:  Radiat Oncol       Date:  2014-12-04       Impact factor: 3.481

8.  Management of predictable pain using fentanyl pectin nasal spray in patients undergoing radiotherapy.

Authors:  Brent C Bell; E Brian Butler
Journal:  J Pain Res       Date:  2013-12-11       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.